Evidence that cataract surgery lowers intraocular pressure (IOP), and the emergence of microinvasive glaucoma surgery (MIGS), prompted reconsideration of traditional glaucoma treatment paradigms. MIGS has the potential to be a major asset, offering patients a safe, non-topical drop therapeutic option.
Current glaucoma treatments while potent, are associated with potentially serious risks, including vision loss. This Focal Points module reviews the current rationale, indications, approaches, and surgical techniques for MIGS in combination with cataract surgery.
Upon completion of this module, you will be able to:
- Describe mechanisms of action and clinical results of IOP lowering of cataract surgery.
- Define MIGS, including its differentiating features and target population.
- Explain available MIGS options, their mechanisms of action, surgical techniques, and clinical results in combination with cataract surgery.
- Describe future MIGS options.
Authors: Iqbal “Ike” K. Ahmed, MD
Consultants: Anup K. Khatana, MD; Steven D. Vold, MD
Focal Points issues are practical, hands-on discussions of the clinical issues you face daily. Each issue delivers high-quality, trusted ophthalmic information written and reviewed by leading experts.
Subscribers receive 12 issues a year, plus access to the Focal Points digital archive.
To access this issue from your laptop or desktop computer, log in to www.aao.org/myonlineproducts with your Academy username and password.
To access this issue from your smartphone or tablet, use the free AAO eBooks app.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.